LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading on TSX Venture Exchange Medical Device Investing
DBV Technologies Files At-The-Market Prospectus for Up to $150 Million of Sales Life Science Investing
Lexston Mining Corporation Provides Update on Additional Services from Hillside Consulting and Media Inc. Life Science Investing
Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers Life Science Investing
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 Life Science Investing
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time Life Science Investing
Allergan Aesthetics receives approval for Boey® , for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients Pharmaceutical Investing
Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts Life Science Investing
